Faten Harb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Faten Harb has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Omar Alqaisi
Nursing Department Al‐Zaytoonah University Amman Jordan
4 shared publications - Patricia Tai
Department of Oncology University of Saskatchewan Saskatoon Saskatchewan Canada
4 shared publications - Mohammed Dibas
Department of Medicine, Faculty of Medicine and Health Sciences An‐Najah National University Nablus Palestine
3 shared publications - Melinda Hysenaj
Faculty of Medicine, University of Prishtina, 10000 Prishtina, Kosovo
2 shared publications - Safia Darwish
Nursing Department Al‐Zaytoonah University Amman Jordan
2 shared publications - Suzan Gharib
Nursing Department Hashemite University Zarqa Jordan
2 shared publications
Latest Publications
- Open Access
- 12 September 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (9) , e72235
Mapping Multilevel Barriers and Facilitators to Inclusive Cancer Care for Sexual and Gender Minority Populations: A Scoping Review
Background: Cancer remains a leading cause of death worldwide, yet advances in prevention, screening, and treatment are not equitably shared. Lesbian, gay, bisexual, transgender, queer/questioning, intersex, asexual, and additional sexual and gender minority (LGBTQIA+) individuals face persistent disparities in cancer care across individual, interpersonal, and institutional levels. This scoping review aimed to improve cancer care for adult LGBTQIA+ patients by mapping and synthesizing evidence on multilevel barriers and facilitators to inclusive cancer care. Methods: A systematic search across PubMed, Scopus, ScienceDirect, and CINAHL was conducted for peer‐reviewed studies published between January 2015 and December 2025. Eligible studies examined cancer care accessibility, delivery, and patient experiences for LGBTQIA+ adults. Results: Twenty studies met the inclusion criteria. Findings revealed critical gaps in provider knowledge. Only 5% of healthcare professionals answered all LGBTQIA+ health questions correctly, 40% reported difficulty addressing sexual health, and 80% expressed interest in LGBTQIA+ training. Among LGBTQIA+ individuals, 65% were uncertain about cancer screening needs, and 76% had not received at least one human papilloma virus vaccine dose. Interpersonal barriers involved inadequate training, communication challenges, and implicit bias. Structural barriers included limited sexual orientation and gender identity fields in electronic records and registries, noninclusive environments, and weak institutional policies. Inclusive communication, routine sexual orientation and gender identity documentation, and visible signals of safety emerged as key facilitators. Conclusions: Inclusive cancer care for LGBTQIA+ adults requires coordinated interventions that address provider education, clinical communication, and system‐level structures simultaneously. Embedding mandatory LGBTQIA+ cultural‐competence training, integrating routine sexual orientation and gender identity collection into electronic health records, and creating visibly welcoming environments represent high‐priority, evidence‐informed strategies to reduce these disparities. Notably, expanding research that meaningfully includes the LGBTQIA+ population is critical toward more equitable cancer care.
- 12 September 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (9) , e72235
Open AccessMapping Multilevel Barriers and Facilitators to Inclusive Cancer Care for Sexual and Gender Minority Populations: A Scoping Review
Background: Cancer remains a leading cause of death worldwide, yet advances in prevention, screening, and treatment are not equitably shared. Lesbian, gay, bisexual, transgender, queer/questioning, intersex, asexual, and additional sexual and gender minority (LGBTQIA+) individuals face persistent disparities in cancer care across individual, interpersonal, and institutional levels. This scoping review aimed to improve cancer care for adult LGBTQIA+ patients by mapping and synthesizing evidence on multilevel barriers and facilitators to inclusive cancer care. Methods: A systematic search across PubMed, Scopus, ScienceDirect, and CINAHL was conducted for peer‐reviewed studies published between January 2015 and December 2025. Eligible studies examined cancer care accessibility, delivery, and patient experiences for LGBTQIA+ adults. Results: Twenty studies met the inclusion criteria. Findings revealed critical gaps in provider knowledge. Only 5% of healthcare professionals answered all LGBTQIA+ health questions correctly, 40% reported difficulty addressing sexual health, and 80% expressed interest in LGBTQIA+ training. Among LGBTQIA+ individuals, 65% were uncertain about cancer screening needs, and 76% had not received at least one human papilloma virus vaccine dose. Interpersonal barriers involved inadequate training, communication challenges, and implicit bias. Structural barriers included limited sexual orientation and gender identity fields in electronic records and registries, noninclusive environments, and weak institutional policies. Inclusive communication, routine sexual orientation and gender identity documentation, and visible signals of safety emerged as key facilitators. Conclusions: Inclusive cancer care for LGBTQIA+ adults requires coordinated interventions that address provider education, clinical communication, and system‐level structures simultaneously. Embedding mandatory LGBTQIA+ cultural‐competence training, integrating routine sexual orientation and gender identity collection into electronic health records, and creating visibly welcoming environments represent high‐priority, evidence‐informed strategies to reduce these disparities. Notably, expanding research that meaningfully includes the LGBTQIA+ population is critical toward more equitable cancer care.
- Open Access
- 16 July 2026
- Published by Springer Nature in BMC Nursing
- Vol. 25 (1)
Nurses’ stigmatizing attitudes toward patients with substance use disorders and their impact on care quality
Stigmatizing attitudes among nurses toward patients with substance use disorders (SUDs) and Opioid Use Disorder (OUD) represent a significant and pervasive
- 16 July 2026
- Published by Springer Nature in BMC Nursing
- Vol. 25 (1)
Open AccessNurses’ stigmatizing attitudes toward patients with substance use disorders and their impact on care quality
Stigmatizing attitudes among nurses toward patients with substance use disorders (SUDs) and Opioid Use Disorder (OUD) represent a significant and pervasive
- Open Access
- 25 June 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (7) , 386
Effectiveness of Nurse-Led Digital Health Interventions on Symptom Management and Quality of Life in Cancer Patients Undergoing Systemic Therapy: A Systematic Review of Randomized Controlled Trials
Cancer patients receiving systemic therapy experience substantial treatment-related symptoms. Nurse-led digital health interventions, e.g., interactive voice response systems, web platforms, mobile apps, and telehealth, have emerged as strategies to strengthen supportive care. To evaluate its effectiveness, this systematic review summarizes evidence exclusively from randomized controlled trials (RCTs). Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, four databases were searched from inception to January 2025 for eligible RCTs involving adults undergoing anticancer therapy; evaluating nurse-led or nurse-co-led interventions using digital or telecommunication technologies; reporting validated symptom or health-related quality of life (HRQoL) outcomes. Risk of bias was assessed. Nine RCTs (N = 3344) met criteria; seven had low risk of bias. Interventions using telephone systems, web portals, mobile apps, or videoconferencing reduced symptom burden and improved HRQoL. The Symptom Care at Home system reduced symptom burden by ~43%, with greatest effects from combined automated monitoring and nurse practitioner follow-up. Additional benefits included improved anxiety, self-efficacy, patient participation, fewer severe toxicities and hospitalization days. In conclusion, nurse-led digital interventions effectively reduce symptom burden and support HRQoL during systemic therapy. Multicomponent models integrating automated monitoring with structured nursing follow-up and decision support appear most beneficial.
- 25 June 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (7) , 386
Open AccessEffectiveness of Nurse-Led Digital Health Interventions on Symptom Management and Quality of Life in Cancer Patients Undergoing Systemic Therapy: A Systematic Review of Randomized Controlled Trials
Cancer patients receiving systemic therapy experience substantial treatment-related symptoms. Nurse-led digital health interventions, e.g., interactive voice response systems, web platforms, mobile apps, and telehealth, have emerged as strategies to strengthen supportive care. To evaluate its effectiveness, this systematic review summarizes evidence exclusively from randomized controlled trials (RCTs). Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, four databases were searched from inception to January 2025 for eligible RCTs involving adults undergoing anticancer therapy; evaluating nurse-led or nurse-co-led interventions using digital or telecommunication technologies; reporting validated symptom or health-related quality of life (HRQoL) outcomes. Risk of bias was assessed. Nine RCTs (N = 3344) met criteria; seven had low risk of bias. Interventions using telephone systems, web portals, mobile apps, or videoconferencing reduced symptom burden and improved HRQoL. The Symptom Care at Home system reduced symptom burden by ~43%, with greatest effects from combined automated monitoring and nurse practitioner follow-up. Additional benefits included improved anxiety, self-efficacy, patient participation, fewer severe toxicities and hospitalization days. In conclusion, nurse-led digital interventions effectively reduce symptom burden and support HRQoL during systemic therapy. Multicomponent models integrating automated monitoring with structured nursing follow-up and decision support appear most beneficial.
- Open Access
- 20 May 2026
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (3) , e70241
Self‐Efficacy, Self‐Care, Glycaemic Control, and Quality of Life Among Adults With Type 2 Diabetes: A Scoping Review
Introduction: Type 2 diabetes mellitus (T2DM) is no longer just a metabolic diagnosis; it is a daily test of confidence, endurance and quality of life. Traditional measures such as haemoglobin A1c (HbA1c) provide only a partial picture, while patients' beliefs about their ability to manage diabetes may be equally crucial. This scoping review examines how self‐efficacy and self‐care behaviours intersect with glycaemic control and health‐related quality of life (HRQoL) in adults with T2DM across diverse health systems and cultures. Methods: Following the Arksey and O'Malley framework and PRISMA‐ScR guidelines, a systematic search was conducted across four databases covering January 2016 to March 2026. Studies were eligible if they included adults aged ≥ 18 years with confirmed T2DM and examined at least one of the following: diabetes self‐efficacy, self‐care behaviours, glycaemic control (HbA1c) or HRQoL. Thirteen studies encompassing 5784 adults with T2DM were included, spanning cross‐sectional, longitudinal, quasi‐experimental and randomised controlled trial designs across seven countries. Results: Diabetes management self‐efficacy consistently outperformed knowledge in predicting self‐care behaviours and HbA1c, with patients holding stronger efficacy beliefs demonstrating better metabolic control and higher HRQoL. Interventions grounded in social cognitive theory and empowerment approaches achieved clinically meaningful HbA1c reductions alongside improvements in self‐care and quality of life. Advanced modelling identified a psychological cascade whereby health literacy enhanced empowerment and self‐efficacy, which in turn drove self‐care and improved glycaemic and HRQoL outcomes. Cluster analyses further revealed distinct high‐risk subgroups, underscoring the need for stratified, individualised interventions. Conclusion: In T2DM, self‐efficacy consistently emerged as a central psychological factor associated with self‐care behaviour, glycaemic control and quality of life. The available evidence suggests that theoretically grounded, individually tailored interventions addressing psychological and behavioural determinants, including self‐efficacy, self‐care, empowerment and resilience, hold promise for improving diabetes outcomes. However, further longitudinal and experimental research is needed to confirm these relationships.
- 20 May 2026
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (3) , e70241
Open AccessSelf‐Efficacy, Self‐Care, Glycaemic Control, and Quality of Life Among Adults With Type 2 Diabetes: A Scoping Review
Introduction: Type 2 diabetes mellitus (T2DM) is no longer just a metabolic diagnosis; it is a daily test of confidence, endurance and quality of life. Traditional measures such as haemoglobin A1c (HbA1c) provide only a partial picture, while patients' beliefs about their ability to manage diabetes may be equally crucial. This scoping review examines how self‐efficacy and self‐care behaviours intersect with glycaemic control and health‐related quality of life (HRQoL) in adults with T2DM across diverse health systems and cultures. Methods: Following the Arksey and O'Malley framework and PRISMA‐ScR guidelines, a systematic search was conducted across four databases covering January 2016 to March 2026. Studies were eligible if they included adults aged ≥ 18 years with confirmed T2DM and examined at least one of the following: diabetes self‐efficacy, self‐care behaviours, glycaemic control (HbA1c) or HRQoL. Thirteen studies encompassing 5784 adults with T2DM were included, spanning cross‐sectional, longitudinal, quasi‐experimental and randomised controlled trial designs across seven countries. Results: Diabetes management self‐efficacy consistently outperformed knowledge in predicting self‐care behaviours and HbA1c, with patients holding stronger efficacy beliefs demonstrating better metabolic control and higher HRQoL. Interventions grounded in social cognitive theory and empowerment approaches achieved clinically meaningful HbA1c reductions alongside improvements in self‐care and quality of life. Advanced modelling identified a psychological cascade whereby health literacy enhanced empowerment and self‐efficacy, which in turn drove self‐care and improved glycaemic and HRQoL outcomes. Cluster analyses further revealed distinct high‐risk subgroups, underscoring the need for stratified, individualised interventions. Conclusion: In T2DM, self‐efficacy consistently emerged as a central psychological factor associated with self‐care behaviour, glycaemic control and quality of life. The available evidence suggests that theoretically grounded, individually tailored interventions addressing psychological and behavioural determinants, including self‐efficacy, self‐care, empowerment and resilience, hold promise for improving diabetes outcomes. However, further longitudinal and experimental research is needed to confirm these relationships.